Literature DB >> 19918314

Induction of antigen-specific immune tolerance by TGF-beta-induced CD4+Foxp3+ regulatory T cells.

Huimin Fan, Julie Wang, Xiaohui Zhou, Zhongmin Liu, Song Guo Zheng.   

Abstract

Like natural CD4(+)CD25(+) Treg cells, TGF-beta-induced Treg cells also prevent allograft rejection in MHC-mismatched organ transplantation models. In analyzing this effect with greater detail, we determined that injection of TGF-beta-induced, alloactivated CD4(+)CD25(+) cells induces antigen-specific immune tolerance in vivo. Increased CD4(+)CD25(+) cells in recipients contribute to this immune tolerance. In addition, adoptive transfer of TGF-beta-induced CD4(+)CD25(+) cells did not result in significant toxic and side effects in recipients. These results indicate that TGF-beta-induced, alloactivated CD4(+)CD25(+) cells may provide a safe and effective approach to protect MHC-mismatched organ grafts from rejection in a clinical setting.

Entities:  

Keywords:  Foxp3; Immunoregulation; TGF-β; regulatory T cells; transplant tolerance

Year:  2009        PMID: 19918314      PMCID: PMC2770184     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.

Authors:  Andre van van Maurik; Manuela Herber; Kathryn J Wood; Nick D Jones
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

2.  Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.

Authors:  Song Guo Zheng; J Dixon Gray; Kazuo Ohtsuka; Satoshi Yamagiwa; David A Horwitz
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

4.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

5.  Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.

Authors:  I Esmé Dijke; Sander S Korevaar; Kadir Caliskan; Aggie H M M Balk; Alex P W M Maat; Willem Weimar; Carla C Baan
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

6.  CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.

Authors:  Song Guo Zheng; Ju Hua Wang; Michael N Koss; Francisco Quismorio; J Dixon Gray; David Allen Horwitz
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

7.  CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance.

Authors:  Jose Trani; Daniel J Moore; Beth P Jarrett; Joseph W Markmann; Major K Lee; Andrew Singer; Moh-Moh Lian; Brian Tran; Andrew J Caton; James F Markmann
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

8.  Regulatory CD25+ T cells in human kidney transplant recipients.

Authors:  Alan D Salama; Nader Najafian; Michael R Clarkson; William E Harmon; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

9.  Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

Authors:  Detlef Dieckmann; Cord Henrik Bruett; Heidi Ploettner; Manfred Bernhard Lutz; Gerold Schuler
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  6 in total

1.  Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.

Authors:  Hanbo Hu; Xiaoyan Zhu; Sunil Joshi; Li Lu; Chang-Qing Xia; Jawaharlal M Patel
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

2.  Characterization of Schistosoma japonicum CP1412 protein as a novel member of the ribonuclease T2 molecule family with immune regulatory function.

Authors:  Xue-Dan Ke; Shuang Shen; Li-Jun Song; Chuan-Xin Yu; Mihoko Kikuchi; Kenji Hirayama; Hong Gao; Jie Wang; Xuren Yin; Yuan Yao; Qian Liu; Wei Zhou
Journal:  Parasit Vectors       Date:  2017-02-17       Impact factor: 3.876

Review 3.  Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases.

Authors:  Yujia Zhai; Reza Moosavi; Mingnan Chen
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

Review 4.  Immunomodulatory Function of Vitamin D and Its Role in Autoimmune Thyroid Disease.

Authors:  Rui Zhao; Wei Zhang; Chenghong Ma; Yaping Zhao; Rong Xiong; Hanmin Wang; Weiwen Chen; Song Guo Zheng
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

5.  Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability.

Authors:  Qi Wang; Jianwei He; Dallas B Flies; Liqun Luo; Lieping Chen
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

6.  Therapeutic Effect of Exogenous Regulatory T Cells on Collagen-induced Arthritis and Rheumatoid Arthritis.

Authors:  Shutong Li; Hongxing Wang; Hui Wu; Xiaotian Chang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.